What is MOTS-c?
MOTS-c (mitochondrial open reading frame of the 12S rRNA-c) is a 16-amino-acid peptide encoded within the mitochondrial genome — specifically within the 12S ribosomal RNA gene region, rather than the nuclear genome where the vast majority of signaling peptides originate. This mitochondrial origin makes MOTS-c a member of a small and structurally distinct class of signaling molecules collectively termed mitochondrial-derived peptides (MDPs). Its sequence is MRWQEMGYIFYPRKLR, and it is synthesized in mitochondria before being exported to the cytoplasm and, in cell-based models, to the nucleus and extracellular compartment. Published structural and functional analyses classify MOTS-c as a retrograde mitochondrial signal — a peptide through which mitochondria communicate metabolic status to the broader cellular environment. The compound is studied in laboratory research for its involvement in AMPK activation, one-carbon metabolic flux, insulin signaling pathway regulation, and cell-level responses to metabolic and oxidative stress. It is supplied as a lyophilized powder for research use only and is not intended for human use. Ever Vital carries MOTS-c at high purity by HPLC for laboratory research applications.
What is the molecular structure of MOTS-c?
MOTS-c is a 16-amino-acid peptide with the sequence MRWQEMGYIFYPRKLR. Its molecular weight is approximately 2174 Da (the precise value varies by salt form and water of crystallization; researchers should reference the batch Certificate of Analysis for the confirmed molecular weight of each lot). The peptide contains a number of structurally notable residues: arginine at positions 1, 14, and 16 gives the C-terminal region a net positive charge that is relevant to membrane interaction and nuclear translocation studies; tryptophan at position 3 and tyrosine at positions 8 and 11 contribute aromatic side chains that have been characterized by structural analyses examining the peptide's conformation in solution. The methionine at position 1 is the initiator methionine that corresponds to the start of the open reading frame within the 12S rRNA gene. Unlike nuclear-encoded peptides, MOTS-c does not carry a canonical mitochondrial targeting sequence — its localization and export are studied as part of understanding MDP trafficking in cell models. Research-grade MOTS-c is produced by solid-phase peptide synthesis and is verified by HPLC and mass spectrometry for sequence identity and purity.
How is MOTS-c encoded in the mitochondrial genome?
The genomic origin of MOTS-c is what distinguishes it mechanistically from most other characterized bioactive peptides. Mitochondrial DNA (mtDNA) in humans is a circular, double-stranded genome of approximately 16,569 base pairs encoding 13 proteins (all components of the oxidative phosphorylation machinery), 22 transfer RNAs, and 2 ribosomal RNAs. The 12S rRNA gene is one of these two ribosomal RNA genes. Published analyses identified a short open reading frame within the 12S rRNA sequence that, when translated using the standard mitochondrial genetic code, produces the MOTS-c peptide. This finding overturned the assumption that rRNA genes are non-coding with respect to protein products. Because mtDNA is present in hundreds to thousands of copies per cell and each mitochondrion carries its own genome, the potential output capacity of MOTS-c per cell differs mechanistically from nuclear-encoded signaling peptides transcribed from two alleles. Research examining MOTS-c in cellular systems therefore often addresses questions about dose-response at concentrations that are relevant to estimated endogenous output ranges in specific cell types.
What is the relationship between MOTS-c and AMPK activation?
One of the most studied research areas for MOTS-c is its relationship to AMP-activated protein kinase (AMPK), the central cellular energy sensor. AMPK is activated when the cellular AMP:ATP or ADP:ATP ratio rises — conditions associated with energetic stress, nutrient limitation, or mitochondrial dysfunction — and its activation triggers a coordinated shift toward catabolic metabolism and away from anabolic processes. Published research has examined MOTS-c in cell culture and preclinical models in the context of AMPK pathway activity, using phosphorylation of AMPK's Thr172 residue as the standard readout. Mechanistic studies in cell-free and cell-based systems have explored whether MOTS-c-associated AMPK effects involve direct interaction with upstream kinases such as LKB1 or CaMKK2, or whether MOTS-c influences AMPK indirectly through its reported effects on one-carbon metabolic flux and the methionine cycle. This area remains an active subject of investigation. Researchers working on AMPK pathway biology use MOTS-c as a defined exogenous peptide to characterize concentration-response relationships in AMPK activation assays in specific cell types.
What role does the folate and one-carbon metabolic cycle play in MOTS-c research?
Published research has linked MOTS-c to the one-carbon metabolic network — a set of interconnected reactions involving folate derivatives and the methionine cycle that is central to nucleotide biosynthesis, methylation reactions, and cellular redox balance through NADPH production. Specifically, published analyses have described MOTS-c inhibiting the enzyme AICAR transformylase (ATIC) in the de novo purine synthesis pathway, leading to accumulation of AICAR (5-aminoimidazole-4-carboxamide ribonucleotide). AICAR is itself a well-characterized experimental AMPK activator — it is the compound most commonly used to experimentally activate AMPK in cell culture — which provides a proposed mechanistic link between MOTS-c's upstream effects on one-carbon metabolism and downstream AMPK activation. This pathway also connects MOTS-c research to the broader folate cycle, methionine metabolism, and the generation of SAM (S-adenosylmethionine), the universal methyl donor in cellular methylation reactions. Ever Vital's lane in longevity and cellular redox research makes this metabolic intersection particularly relevant, as the same NADPH-generating arms of the one-carbon cycle supply reducing equivalents to glutathione reductase — connecting MOTS-c research to glutathione pathway studies and the cellular redox network.
How is MOTS-c studied in the context of insulin signaling and glucose metabolism research?
Research examining MOTS-c in metabolic cell models has addressed its effects on insulin signaling pathway components, with published work in skeletal muscle cell lines and preclinical models characterizing changes in glucose uptake, GLUT4 translocation, and insulin receptor substrate (IRS) phosphorylation status following MOTS-c treatment in vitro. These studies are conducted in the framework of metabolic research — characterizing how a mitochondrial-derived peptide signal influences cellular glucose handling machinery at the pathway level — not as demonstrations of clinical metabolic outcomes. Cell culture studies have used differentiated C2C12 myotubes (a standard skeletal muscle research model) as a primary system for characterizing MOTS-c concentration-response relationships in glucose uptake assays. Separately, published research has examined MOTS-c in the context of lipid metabolism, characterizing effects on fatty acid oxidation gene expression in hepatocyte models. These in vitro findings establish MOTS-c as a research tool for probing the interface between mitochondrial signaling and metabolic pathway regulation, distinct from any claim regarding metabolic outcomes in organisms or humans. Ever Vital makes no therapeutic claims regarding MOTS-c.
What does published research describe about MOTS-c and cellular stress responses?
MOTS-c has been studied in cell models exposed to a range of metabolic and oxidative stressors, including hydrogen peroxide challenge, nutrient deprivation, and mitochondrial membrane uncoupling. Published research characterizes MOTS-c's effects on cell viability assays and markers of mitochondrial membrane potential under these conditions, framing the peptide as a component of the mitochondrial stress response signaling network. A separate line of research has examined how endogenous MOTS-c levels in cell models change in response to mitochondrial stressors — with some published analyses reporting that cellular MOTS-c output increases under conditions of mitochondrial stress, consistent with a retrograde signaling model in which mitochondria communicate stress status to the cytoplasm and nucleus. Research in this area uses exogenous MOTS-c at defined concentrations to distinguish peptide-dose effects from the endogenous signaling context. Nuclear translocation of exogenously applied MOTS-c has been documented in cell imaging studies, where the peptide has been reported to interact with DNA and influence transcriptional programs — a finding that has motivated research into MOTS-c's potential role as a mitochondria-to-nucleus retrograde signal in stress adaptation models.
How is MOTS-c studied in cellular aging research models?
MOTS-c sits at the intersection of two research fields that are central to Ever Vital's catalog: mitochondrial biology and cellular aging. Published research has used cell culture models of replicative senescence and aged primary cells to characterize changes in endogenous MOTS-c levels and pathway activity relative to younger cell populations. Separately, researchers have examined how exogenous MOTS-c treatment in aged cell models influences markers associated with mitochondrial function, including respiratory capacity, mitochondrial membrane potential, and reactive oxygen species output. These studies frame MOTS-c as a research tool for probing the relationship between mitochondrial-derived signaling and cellular aging phenotypes — not as a demonstration that MOTS-c reverses or treats aging. The observation that MOTS-c is encoded in mitochondrial DNA — a genome that accumulates mutations with age in cell models — provides a mechanistic basis for asking whether changes in mitochondrial genome integrity influence MOTS-c production and downstream signaling in aged cells. This question is actively studied using cell-based aging models. For researchers working across the mitochondrial and redox aging research space, Ever Vital also carries NAD+, a coenzyme whose cellular availability has been extensively studied alongside sirtuin pathway activity in cellular aging models.
How should MOTS-c be handled for research use?
MOTS-c is supplied as a lyophilized white powder and is stored at −20°C to maintain peptide integrity. As with other synthetic peptides, the primary degradation pathways of concern are peptide bond hydrolysis under acidic or alkaline conditions, oxidation of the methionine and tryptophan side chains, and aggregation in aqueous solution at higher concentrations. Research handling best practices include maintaining cold storage, avoiding repeated freeze-thaw cycles with any prepared solutions, and verifying mass spectrometric identity against the expected molecular weight for the specific salt form supplied. This article does not provide preparation or solution-making protocols; those procedures are determined by the investigator according to experimental requirements and applicable laboratory guidelines. For guidance on interpreting batch-level analytical documentation, including mass spectrometry confirmation and HPLC purity traces, see the Ever Vital guide on reading a Certificate of Analysis. Researchers can access specifications, current pricing, and documentation on the MOTS-c product page, or browse the complete research catalog at all compounds.
This compound is a research chemical intended for laboratory and scientific research purposes only. It is not a drug, supplement, or food, and is not intended to diagnose, treat, cure, or prevent any disease. Ever Vital does not sell products intended for human use. Researchers are responsible for compliance with all applicable local, state, and federal regulations.